EU Yes For TiGenix Marks Tenth ATMP Approval in Ten Years

 
• By Neena Brizmohun

TiGenix says its treatment for complex perianal fistulae in Crohn’s disease is the first allogeneic stem cell therapy to be approved under Europe’s centralized marketing authorization pathway.

Concept of national healthcare system - EU - European Union
TiGenix has received approval to market Alofisel across the EU

More from Approvals

More from Product Reviews